TX-FLUENCE
29.2.2024 14:31:32 CET | Business Wire | Press release
Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced its newest LED top light solutions for produce and ornamental cultivators: RAPTR 2 and VYPR 4.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240229846318/en/
Fluence announced its newest LED top light solutions for produce and ornamental cultivators: RAPTR 2 and VYPR 4. (Photo: Business Wire)
Fluence’s latest LED innovations were developed in parallel with the company’s global research program, which includes partnerships with industry leaders worldwide and in-house analysis of spectral optimization across crops. The new RAPTR and VYPR offerings build upon Fluence’s existing portfolio of lighting solutions to offer robust fixtures with higher wattages, greater efficiencies and overall increased ROI for growers throughout the world.
RAPTR 2: Higher wattages and tunable spectra help growers maximize light output and efficiency at lower installation costs
The RAPTR 2 fixture’s wide power range (up to 1400 W), multi-channel tunable spectra and up to 5050 μmol/s of light output make it the optimal lighting solution for upgrading HPS fixtures in greenhouse environments. Featuring steerable spectra—including far red—integrated wireless dimming capability and efficacies up to 4.0 μmol/J, cultivators can achieve improved crop performance and lower operating expenses with the new RAPTR 2.
“The latest RAPTR and VYPR series luminaires showcase that Fluence’s primary mission remains unchanged: Help the world grow smarter through the most advanced LED fixtures,” said Steve Graves, senior vice president of strategy and business development at Fluence. “We're excited to launch our most powerful and efficient solutions yet and we look forward to advancing the industry together with partners across the globe.”
VYPR 4: More versatility and control that maximizes cultivation results
Featuring the VYPR line’s familiar low-profile design, VYPR 4 offers more spectral options, light uniformity at any mounting height, easy installation and higher light intensities with lower energy consumption.
“VYPR 4 is a versatile top light solution,” said Jordon Musser, chief product officer for Fluence. “The latest generation focuses on what every grower wants: a more efficient output that yields a clear ROI. Installation is swift, the fixtures are extremely durable, and growers can tap into Fluence’s diverse spectral options to curate a lighting program unique to their cultivation goals.”
VYPR 4 features output up to 3030 μmol/s and efficiency up to 3.9 μmol/J. The fixture also includes dual-channel far red spectra as well as Fluence’s wide variety of PhysioSpec™ spectra to empower growers with multiple lighting strategies. VYPR 4’s low profile creates the least possible shading in a greenhouse environment and now offers a wide-beam optic for optimized light distribution.
Fluence will showcase RAPTR 2 and VYPR 4 during its upcoming global trade shows, including HortiContact from March 5 to March 7, 2024 in the Netherlands.
To learn more about the RAPTR and VYPR series and how to schedule a trial at your facility, visit www.fluence-led.com.
About Fluence
Fluence Bioengineering, Inc. (Fluence) creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis, produce and flower markets, committed to enabling more efficient crop production for the world’s top greenhouse and indoor growers. Fluence global headquarters are in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. Fluence operates as a business unit within Signify’s Professional Business. For more information about Fluence, visit www.fluence-led.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240229846318/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity30.1.2026 07:00:00 CET | Press release
Results from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of menopause on the skin, despite women experiencing around three skin changes during menopause1 Galderma will also host a symposium delving into the challenges and science behind menopause-related skin changes and aesthetic solutions at the congress Galderma is committed to raising awareness of the impact of menopause on the skin, fostering meaningful dialogue between patients and healthcare professionals, and advancing science-backed solutions by incorporating menopausal status into all injectable aesthetics clinical trials Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-menopausal women from nine countries exploring the impact of menopause on the skin at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The survey found that over 50% of women learne
Andersen Consulting styrker sine cybersikkerhedskompetencer med tilføjelsen af RedLegg30.1.2026 00:18:00 CET | Pressemeddelelse
Andersen Consulting styrker sit cybersikkerhedsudbud gennem en samarbejdsaftale med RedLegg, der er et cybersikkerhedsfirma med speciale i administreret trusselsdetektion og rådgivningsydelser. RedLegg blev grundlagt i 2008 og har hovedsæde i USA. RedLegg tilbyder skræddersyede cybersikkerhedsløsninger med fokus på risikominimering, administrerede sikkerhedstjenester og penetrationstest. Virksomhedens ydelser omfatter blandt andet managed detection and response (MDR), hændelsesrespons, udvikling af sikkerhedspolitikker samt virtuel CISO-rådgivning. RedLegg betjener mellemstore virksomheder inden for finans, forsikring, jura og sundhedssektoren og kombinerer automatisering, trusselsintelligens og et dedikeret Security Operations Center (SOC) for at hjælpe organisationer med at effektivisere deres cybersikkerhedsoperationer og opbygge langsigtet modstandsdygtighed. "Vores fokus har altid været at hjælpe kunder med at skære støjen fra og prioritere det, der virkelig betyder noget – nemlig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
